Autoimmune polyendocrine syndrome type 1: Utility of KCNRG autoantibodies as a marker of active pulmonary disease and successful treatment with rituximab.
Saved in:
| Title: | Autoimmune polyendocrine syndrome type 1: Utility of KCNRG autoantibodies as a marker of active pulmonary disease and successful treatment with rituximab. |
|---|---|
| Authors: | Popler J; Georgia Pediatric Pulmonology Associates, Atlanta, Georgia 3042, USA. JPopler@gppa.net, Alimohammadi M, Kämpe O, Dalin F, Dishop MK, Barker JM, Moriarty-Kelsey M, Soep JB, Deterding RR |
| Source: | Pediatric pulmonology [Pediatr Pulmonol] 2012 Jan; Vol. 47 (1), pp. 84-7. Date of Electronic Publication: 2011 Sep 07. |
| Publication Type: | Case Reports; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8510590 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1099-0496 (Electronic) Linking ISSN: 10990496 NLM ISO Abbreviation: Pediatr Pulmonol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
